Jordan Milner

Trials

Studies that name Jordan Milner as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:11 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06731036 · Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

  University of Florida · available · Severe Combined Immunodeficiency, Fanconi Anemia, Dyskeratosis Congenita · principal investigator
• Ph1/Ph2
  NCT06625190 · Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

  University of Florida · recruiting · Neuroblastoma, Rhabdomyosarcoma, Synovial Sarcoma · principal investigator
• Ph2
  NCT05800210 · Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

  University of Florida · recruiting · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia · principal investigator
• Ph1/Ph2
  NCT05322850 · Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

  University of Florida · recruiting · Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.